Last viewed:
AERI
Prices are updated after-hours
AERI
|
$15.25
0.0%
|
Health Technology
(0.0% 1d)
(0.0% 1m)
(0.0% 1y)
(0.0% 2d)
(0.0% 3d)
(0.0% 7d)
(13.48%
volume)
Earnings Calendar: 2023-02-23
Market Cap: $ 753,615,457
http://www.aeriepharma.com
Sec
Filling
|
Patents
| 380 employees
(US) Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.
eye
treatment
Drugs
Rhopressa
(netarsudil )
Rocklatan
(netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% )
add to watch list
Paper trade
email alert is off
Press-releases
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
Published: 2023-10-27
(Crawled : 10:00)
- globenewswire.com
OPT
|
News
|
$3.36
-0.59%
2.37%
2K
|
Health Technology
| 110.0%
| O: 1.25%
H: 5.8%
C: 2.47%
ceo
Optic Nerves Disorder Treatment Market Rises: North America Takes the Helm
Published: 2023-09-14
(Crawled : 00:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
| 15.36%
| O: 1.84%
H: 0.0%
C: 0.0%
PFE
|
News
4
|
$26.32
0.23%
0.15%
88K
|
Health Technology
| -22.77%
| O: 0.47%
H: 0.41%
C: -0.26%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
| -1.91%
| O: 0.28%
H: 1.0%
C: 0.76%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
| 13.52%
| O: 1.78%
H: 1.76%
C: 1.07%
america
treatment
market
DelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain
Published: 2023-05-23
(Crawled : 15:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
| 13.64%
| O: -1.22%
H: 0.0%
C: -0.62%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
| -1.87%
| O: 0.74%
H: 0.0%
C: -1.22%
GKOS
|
$101.1
2.17%
0.0%
350K
|
Health Technology
| 70.49%
| O: -0.71%
H: 2.06%
C: -1.05%
BHC
|
$8.53
0.95%
0.0%
500
|
Health Technology
| -3.07%
| O: -2.27%
H: 4.24%
C: -2.21%
ALC
|
$80.76
0.19%
0.0%
880K
|
Health Technology
| -1.17%
| O: -0.51%
H: 0.02%
C: -3.25%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
| 17.0%
| O: -0.31%
H: 0.26%
C: -1.34%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
| -13.41%
| O: -0.01%
H: 0.0%
C: 0.0%
OCUL
|
News
|
$5.0
-1.48%
-1.5%
0
|
Health Technology
| -23.2%
| O: 4.45%
H: 7.65%
C: 2.21%
GRFS
|
$6.48
2.86%
2.85%
1.5K
|
Health Technology
| -28.08%
| O: 0.78%
H: 0.0%
C: -3.74%
ALDX
|
$3.91
-0.51%
-0.51%
450
|
Health Technology
| -59.94%
| O: 0.0%
H: 2.36%
C: 0.61%
pharma
disease
pipeline
set
eye
trial
Optic Nerve Disorder Treatment Market to Reach USD 5.3 Billion, Globally, by 2031 at 4.5% CAGR: Allied Market Research
Published: 2023-02-27
(Crawled : 07:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.15%
88K
|
Health Technology
| -36.96%
| O: -0.74%
H: 0.7%
C: -1.59%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
| 15.46%
| O: 0.64%
H: 0.01%
C: -0.72%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
| 11.02%
| O: 0.36%
H: 0.97%
C: 0.67%
treatment
research
market
Antiglaucoma Drugs Global Market Report 2023
Published: 2023-02-20
(Crawled : 18:00)
- prnewswire.com
AERI
|
$15.25
0.0%
|
Health Technology
| Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
| Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
| Email alert
Add to watchlist
PFE
|
News
4
|
$26.32
0.23%
0.15%
88K
|
Health Technology
| Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
| Email alert
Add to watchlist
global
report
market
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
Published: 2022-11-22
(Crawled : 10:00)
- biospace.com/
ALC
|
$80.76
0.19%
0.0%
880K
|
Health Technology
| 22.47%
| O: 1.79%
H: 0.07%
C: -0.33%
KALA
|
$6.5661
3.73%
4.24%
0
|
Health Technology
| 10.61%
| O: 0.34%
H: 0.5%
C: -2.01%
acquisition
Global Glaucoma Treatment Market to Grow at 5.2% Annually Through 2027
Published: 2022-09-28
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
1.67%
-2.18%
480
|
Health Technology
| 24.29%
| O: 0.22%
H: 0.33%
C: 0.33%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
| 54.88%
| O: 1.87%
H: 0.0%
C: 0.0%
PFE
|
News
4
|
$26.32
0.23%
0.15%
88K
|
Health Technology
| -40.76%
| O: -0.05%
H: 0.47%
C: -0.56%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
| 29.53%
| O: 0.17%
H: 1.1%
C: 0.16%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
| -10.15%
| O: -0.05%
H: 0.41%
C: -1.17%
SNY
|
News
|
$47.69
1.15%
1.13%
1.6M
|
Health Technology
| 24.53%
| O: -0.13%
H: 0.0%
C: 0.0%
REGN
|
News
|
$907.32
0.8%
0.74%
220K
|
Health Technology
| 28.62%
| O: -0.08%
H: 0.25%
C: -1.85%
AERI
|
$15.25
0.0%
|
Health Technology
| 0.73%
| O: 0.13%
H: 0.0%
C: -0.13%
treatment
glaucoma
global
market
AERIE PHARMACEUTICALS - INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
Published: 2022-09-27
(Crawled : 19:00)
- prnewswire.com
ALC
|
$80.76
0.19%
0.0%
880K
|
Health Technology
| 40.14%
| O: -1.04%
H: 2.02%
C: 1.61%
AERI
|
$15.25
0.0%
|
Health Technology
| 0.66%
| O: 0.0%
H: 0.2%
C: -0.07%
pharmaceuticals
alert
EQUITY ALERT: The M&A Class Action Firm Launches Merger Inquiry - VIVO, AERI, CYBE, GMTX
Published: 2022-09-24
(Crawled : 20:20)
- prnewswire.com
AERI
|
$15.25
0.0%
|
Health Technology
| Email alert
Add to watchlist
ALC
|
$80.76
0.19%
0.0%
880K
|
Health Technology
| Email alert
Add to watchlist
Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options
Published: 2022-09-13
(Crawled : 13:00)
- biospace.com/
AERI
|
$15.25
0.0%
|
Health Technology
| 0.73%
| O: 0.0%
H: 0.4%
C: 0.13%
treatment
eye
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001209191-22-058191
4
2022-11-21
2022-11-21
Sell
D
7800
0
0001209191-22-058191
4
2022-11-21
2022-11-21
Sell
D
16095
0
0001209191-22-058189
4
2022-11-21
2022-11-21
Sell
D
7800
0
0001209191-22-058189
4
2022-11-21
2022-11-21
Sell
D
41984
0
0001209191-22-058188
4
2022-11-21
2022-11-21
Sell
D
16854
0
0001209191-22-058188
4
2022-11-21
2022-11-21
Sell
D
7995
0